PROTEIN REKOMBINAN SUB-UNIT L TIROSINASE DARI JAMUR AGARICUS BISPORUS SEBAGAI PEMBAWA UNTUK SISTEM PENGHANTARAN ORAL: KAJIAN AWAL PEMBERIAN BERULANG PADA MENCIT GALUR SWISS WEBSTER
Oral drug delivery system is widely developed, but low bioavailability of the drug is the major problem. Thus, research nowadays focuses on the development of excipient or drug carrier to improve bioavailability by enhancing gut penetration. Light Sub-Unit Mushroom Tyrosinase (LSMT) is a protein...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/44543 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Oral drug delivery system is widely developed, but low bioavailability of the drug is the major
problem. Thus, research nowadays focuses on the development of excipient or drug carrier to
improve bioavailability by enhancing gut penetration. Light Sub-Unit Mushroom Tyrosinase (LSMT)
is a protein that was first discovered in button mushrooms (Agaricus bisporus). Tyrosinase has light
sub-units and heavy sub-units. These sub-units show different activity, H sub-unit shows
tyrosinase enzyme activity, while L sub-unit shows no activity as tyrosinase enzyme. The L sub-unit
(LSMT) exhibits a lectin-like structure, a structure that highly similar with HA 33 from Clostridium
botulinum and CNL from Clitocybe nebularis which have been used as drug carriers to improve
bioavailability. The lectin-like structure is able to interact with glycosylated structures on the
epithelial surface of small intestine that conducts to endocytosis or transcytosis. However, protein
application may have negative impact due to the immunogenicity and toxicity. As an early stage to
ensure safety use, animals response to LSMT was evaluated after intraperitoneal administration
once a week to healthy male and female Swiss Webster mice to simply avoid the complexity of
oral absorbtion. The experiment was performed for 12 weeks. Several parameters were observed
including body weight, serum IgG, organ indices, and organ histology. Dot Blot method was used
to evaluate the antibody IgG generation as an immune response against LSMT. After 12 weeks of
administration, animals were sacrificed and primary organs (liver, spleen, heart, lungs, and kidney)
were isolated to assess organ indices number and microscopic observation. The result of Dot Blot
method indicates that there was no specific antibody generated as a response after 12 weeks of
LSMT administration. Based on Independent-Samples T Test statistical analysis of body weight and
organ indices, significant difference was considered if p<0,05, the difference between test and
control groups were not significant statistically. Microscopical observation showed no significant
difference between test and control groups primary organs.
|
---|